Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/ccd.30885 | DOI Listing |
Eur Heart J Case Rep
December 2024
Department of Cardiology, Sendai Kousei Hospital, 1-20, Tsutsumidori Amamiya-cho, Aoba-ku, Sendai, Miyagi 981-0914, Japan.
Background: Balloon-assisted bioprosthetic or native aortic scallop intentional laceration to prevent iatrogenic coronary artery obstruction (BA-BASILICA) enables valve-in-valve transcatheter aortic valve implantation (ViV-TAVI) in patients at risk of coronary artery obstruction. However, its efficacy in patients with severely calcified leaflets remains unclear.
Case Summary: We report a 78-year-old woman with a deteriorated 21 mm Carpentier-Edwards PERIMOUNT Magna valve.
Catheter Cardiovasc Interv
September 2024
JACC Case Rep
February 2024
Department of Cardiac Surgery, Heart Valve Center, IRCCS San Raffaele Hospital, Milan, Italy.
Valve-in-ring procedures represent a feasible solution for high-risk patients with surgical repair failure. The risk of left ventricular outflow tract obstruction increases the challenge, and transcatheter approaches to prevent it are technically demanding and often do not resolve it. We demonstrate the feasibility and safety of a transseptal balloon-assisted translocation of the anterior mitral leaflet for valve-in-ring implantation.
View Article and Find Full Text PDFJACC Cardiovasc Interv
February 2024
Cardio Center, Humanitas Clinical and Research Hospital IRCCS, Rozzano, Milan, Italy.
Catheter Cardiovasc Interv
November 2023
Division of Cardiovascular Disease, Ochsner LSU Health Science Center, Shreveport, Louisiana, USA.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!